Expression of UBQLN-1 and RUNX3 in rectal cancer tissues and their clinical significance
SUN Guangyuan1 GUO Shengchao2 WU Xueliang1 XUE Jun1 QU Ming1 GUO Fei1 HAN Lei1 HAN Jie3
1.Department of General Surgery, the First Affiliated Hospital of Hebei North University, Hebei Province, Zhangjiakou 075061, China;
2.Graduate School, Hebei North University, Hebei Province, Zhangjiakou 075061, China;
3.Department of Ophtalmology, the Fourth Hospital of Zhangjiakou, Hebei Province, Zhangjiakou 075061, China
Abstract：Objective To explore the expression of UBQLN-1 and RUNX3 in rectal cancer tissues and clinical significance. Methods From June 2017 to June 2019, 85 cases of rectal cancer tissues and adjacent normal tissues were selected from the First Affiliated Hospital of Hebei North University were selected. The mRNA and protein levels of UBQLN-1 and RUNX3 were detected by reverse transcription polymerase chain reaction (RT-PCR) and immunohistochemistry and the relationship between UBQLN-1, RUNX3 and the clinicopathological characteristics of tumors and the correlation between their expressions were analyzed. Results The expression of UBQLN-1 mRNA in rectal cancer tissues was higher than that in adjacent normal tissues; and the expression of RUNX3 mRNA in rectal cancer tissues was lower than that in adjacent normal tissues，and the differences were highly statistically significant (P ＜ 0.01). The positive expression rate of UBQLN-1 in rectal cancer tissues was higher than that in adjacent normal tissues and the positive expression rate of RUNX3 was lower than that of adjacent normal tissues, with highly statistically significant differences (P < 0.01). UBQLN-1 was negatively correlated with RUNX3 expression in rectal cancer tissues（r = -0.225, P = 0.038）. Conclusion The abnormal expressions of UBQLN-1 and RUNX3 in the rectal cancer tissues are closely related to their development and evolution, and rectal cancer tissues and adjacent normal tissues are significantly negatively correlated, which can be used as potential molecular biological indicators for the diagnosis, treatment and prognosis assessment of rectal cancer.
[1] Bray F，Ferlay J，Soerjomataram I，et al. Global cancer statistics 2018：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin，2018，68：394-424.
[2] 郑荣寿，孙可欣，张思维，等.2015年中国恶性肿瘤流行情况分析[J].中华肿瘤杂志，2019，41（1）：19-28.
[3] Li X，Zhou J，Chen H，et al. The association between the UBQLN1 polymorphism and Alzheimer′s disease risk：A systematic review [J]. Cell Mol Biol，2017，63（5）：94-96.
[4] Yue Z，Wang S，Yan W，et al. Association of UBQ-8i polymorphism with Alzheimer′s disease in Caucasians：a meta-analysis [J]. Int J Neurosci，2015，125（6）：395-401.
[5] Luo L，Liu Y，Tu X，et al. Decreased expression of ubiquilin 1 following neonatal hypoxia ischemic brain injury in mice [J]. Mol Med Rep，2019，19（6）：4597-4602.
[6] Kurlawala Z，Dunaway R，Shah PP，et al. Regulation of insulin-like growth factor receptors by Ubiquilin1 [J]. Biochem J，2017，474（24）：4105-4118.
[7] 薛军，武雪亮，贾光辉，等.RUNX3蛋白在结直肠腺癌中的表达及临床意义[J].河北医药，2013，35（24）：3708-3709.
[8] Weiser MR. AJCC 8th Edition：Colorectal Cancer [J]. Ann Surg Oncol，2018，25（6）：1454-1455.
[9] Ben Brahim E，Ayari I，Jouini R，et al. Expression of epidermal growth factor receptor （EGFR） in colorectal cancer：An immunohistochemical study [J]. Arab J Gastroenterol，2018，19（3）：121-124.
[10] Adegoke OO，Qiao F，Liu Y，et al. Overexpression of Ubiquilin-1 Alleviates Alzheimer′s Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice [J]. J Alzheimers Dis，2017，59（2）：575-590.
[11] Fang X，Trexler C，Chen J，et al. Ushering in the cardiac role of Ubiquilin1 [J]. J Clin Invest，2018，128（12）：5195-5197.
[12] Kim HT，Goldberg AL. UBL domain of Usp14 and other proteins stimulates proteasome activities and protein degradation in cellsl [J]. Proc Natl Acad Sci U S A，2018，115（50）：E11642-E11650.
[13] Liu Y，Qiao F，Wang H. Enhanced Proteostasis in Post-ischemic Stroke Mouse Brains by Ubiquilin-1 Promotes Functional Recovery [J]. Cell Mol Neurobiol，2017，37（7）：1325-1329.
[14] Mizukami K，Abrahamson EE，Mi Z，et al. Immunohistochemical analysis of ubiquilin-1 in the human hippocampus：association with neurofibrillary tangle pathology [J]. Neuropathology，2014，34（1）：11-18.
[15] Bangsow C，Rubins N，Glusman G，et al. The RUNX3 gene：sequence，structure and regulated expression [J]. Gene，2001，279（2）：221-232.
[16] Coffman JA. Runx transcription factors and the developmental balance between cell proliferation and differentiation [J]. Cell Biol Int，2003，27（4）：315-324．
[17] Lotem J，Levanon D，Negreanu V，et al. Runx3 at the interface of immunity，inflammation and cancer [J]. Biochim Biophys Acta，2015，1855（2）：131-143.
[18] Choi SY，Park SK，Yoo HW，et al. Charged Amino Acid-rich Leucine Zipper-1（Crlz-1）as a Target of Wnt Signaling Pathway Controls Pre-B Cell Proliferation by Affecting Runx/CBFβ-targeted VpreB and λ5 Genes [J]. J Biol Chem，2016，291（29）：15008-15019.
[19] 任约翰，蔡剑辉，陈积贤.抑癌基因Runx3在结直肠癌组织中的表达及意义[J].现代肿瘤医学，2018，26（1）：72-76.
[20] 杨琼娇，许淑媛，黄晓明，等.RUNX3和Survivin在卵巢上皮性癌中的表达及其临床意义[J].临床和实验医学杂志，2011，10（2）：87-89.
[21] 薛军，武雪亮，王立坤，等.结直肠腺癌、腺瘤、正常黏膜中RUNX3的表达及意义[J].临床与实验病理学杂志，2014，30（6）：605-609.
[22] 薛军，武雪亮，屈明，等.结直肠癌组织RUNX3和MMP-2表达与MVD相关性研究[J].中华肿瘤防治杂志，2015， 22（24）：1884-1888.
[23] 武雪亮，王立坤，薛军，等.结直肠腺癌中RUNX3表达与微淋巴管密度的关系及临床意义[J].安徽医科大学学报，2014，49（12）：1825-1828.
[24] 薛军，武雪亮，王宇，等.联合检测runt相关转录因子3蛋白和基质金属蛋白酶-9表达在结直肠腺癌中的临床意义[J].中国医师进修杂志，2014，37（29）：22-25.
[25] 薛军，武雪亮，王立坤，等.抑癌基因RUNX3表达与结直肠腺癌的关系[J].重庆医学，2014（22）：2859-2861， 2864.
[26] Feng Y，Gao S，Gao Y，et al. Runx3 expression in rectal cancer cells and its effect on cell invasion and proliferation [J]. Oncol Lett，2019，18（3）：3290-3294.
2020, Vol. 17 
京公网安备 11010502046598号